对于急性损伤住院患者的早期个性化建议:一项随机临床试验
Abinet M Aklilu1,2, Steven Menez3, Megan L Baker2
1Clinical and Translational Research Accelerator, Yale University, New Haven, Connecticut.
JAMA
|October 25, 2024
概括
行动小组的建议并没有显著改善急性损伤 (AKI) 的住院患者的治疗结果. 虽然实施率较高,但AKI进展,透析或死亡率的综合结果保持不变.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 医院 医院 医疗 医疗 医疗 医疗
- 临床信息学 临床信息学
背景情况:
- 急性损伤 (AKI) 是住院患者的常见和严重并发症,经常导致不良健康事件.
- 早期检测和干预对于管理AKI至关重要,但最佳策略仍在调查中.
研究的目的:
- 确定通过电子健康记录 (EHR) 提供的行动小组 (KAT) 的诊断和治疗建议是否改善了与标准护理相比,AKI住院患者的治疗结果.
- 评估KAT干预对AKI进展,透析和死亡率的影响.
主要方法:
- 一项随机临床试验,涉及4003名在美国7家医院的AKI住院患者.
- 患者被随机分配,通过EHR从KAT获得建议,或接受通常的护理.
- 在AKI检测后1小时内,KAT提供了个性化的建议,包括诊断,流体管理,电解质,酸平衡和药物.
主要成果:
- 主要综合结局 (AKI进展,透析或14天内住院死亡率) 发生在干预组的19.8%和通常护理组的18.4% (P=.28).
- 在干预组中,KAT建议的实施率明显高 (33.8%),相比于常规护理组 (24.3%).
- 在干预组和通常护理组之间的初级复合结果中没有发现显著差异.
结论:
- 尽管建议的执行率更高,但脏行动小组的干预措施并没有显著减少住院患者恶化的AKI,透析或死亡的复合结果.
- 可能需要进一步的研究来优化KAT干预措施或探索替代策略,以改善AKI在医院环境中的结果.
相关概念视频
01:11Renal Failure: Dose Adjustments
67
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
67
01:17Factors Affecting Renal Clearance: Renal Impairment
58
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
58
01:27Dialysis
272
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
272
01:22Heart Failure VI: Adjunct Therapies
1
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
1
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
394
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
394
01:22Heart Failure Drugs: Diuretics
346
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
346